Finishing treatment for a urinary tract infection can feel like a relief. Then comes the thought: you would really rather not go through it again.
So, does cranberry for UTI prevention actually help? Human studies suggest some cranberry products may lower the chance of another symptomatic UTI in women with repeat infections. A large Cochrane review found a probable benefit, and a 2025 trial reported fewer confirmed infections with a specific cranberry powder. Results vary by person and product. Cranberry does not treat an infection you have now.
If you are looking into everyday support, our cranberry collection is a simple place to explore concentrated cranberry options.
The question cranberry studies are really trying to answer
Prevention studies follow people for months and count whether they develop another UTI. They are not measuring whether cranberry makes burning or urgency disappear today.
A useful measure is a symptomatic, culture-confirmed UTI. This means someone has symptoms and a laboratory test of their urine shows bacterial growth consistent with infection. That matters because urinary discomfort does not always mean a UTI.
Researchers usually compare a group taking cranberry with a group taking a placebo, then count new infections in each. In clinical practice, recurrent UTI generally means at least two infections within six months or three within 12 months. If that sounds familiar, talk with your GP about confirming the cause of each episode.
What the large Cochrane review found
The 2023 Cochrane review combined 50 randomised controlled trials involving 8,857 people. These studies tested cranberry drinks, tablets and capsules in different groups. For women with recurrent UTIs, eight studies involving 1,555 women found that cranberry products probably reduced symptomatic, culture-confirmed UTIs.
The pooled relative risk was 0.74 (95% confidence interval 0.55 to 0.99). In plain language, that means an estimated 26% lower relative risk in the combined studies, not 26 fewer infections for every 100 women.
For illustration, if 20 in 100 women in a comparison group developed another UTI, a 26% lower relative risk would mean roughly 15 in 100 instead. That is an example, not the actual trial result. Your starting risk, and the benefit you might experience, could be different.
Cochrane rated the evidence for women with recurrent UTIs as moderate certainty. That is encouraging: researchers observed fewer confirmed infections, not just changes in a laboratory test. Still, the effect is an average across studied preparations, not a result established for every cranberry supplement.
If a concentrated capsule appeals to you, our XTR Cranberry 100,000 is designed for everyday urinary tract support. The review cannot tell us that our finished capsule produces the same prevention results.
A newer trial gives us another reason to pay attention
In 2025, researchers followed 150 women aged 18 to 65 with recurrent-UTI histories. For six months they took either 500 mg of a particular whole-cranberry fruit powder daily or a placebo. The trial was randomised and double-blind.
For culture-confirmed UTIs, the adjusted relative risk was 0.48, equivalent to a 52% lower relative risk in the cranberry group. Researchers also observed a longer time before the first UTI and fewer total UTI episodes.
Not every outcome showed a clear difference. For example, the change in symptomatic suspected UTIs was not statistically significant. And the trial tested a particular whole-fruit powder, not our concentrated 600:1 extract.
So the result is promising evidence of fewer actual infections with that preparation. It does not mean XTR reduces UTIs by 52%, or that this trial proved a larger effect than the Cochrane review. The studies involved different people, products and methods.
Why cranberry does not work equally well for everyone
Cochrane did not find clear preventive benefit for older men and women in long-term residential care, pregnant women, or adults with certain neuromuscular bladder-emptying problems. The causes of repeat infections can be quite different in these groups.
That does not mean every independently living older woman is unlikely to benefit. Nor can results in younger women automatically be applied to everyone later in life. Your own urinary history matters.
During and after menopause, changes in vaginal and urinary tissues may affect infection risk. A GP can review this and discuss suitable options, including vaginal oestrogen where appropriate. We also cover individual considerations in our article on cranberry supplements for older adults.
What are cranberry PACs, and does the amount matter?
Proanthocyanidins, or PACs, are natural cranberry plant compounds. Laboratory research suggests certain PACs may make it harder for some bacteria, including particular E. coli strains, to attach to urinary tract cells. That may help explain a preventive effect, but PACs do not kill bacteria or treat an active infection.
Why 36 mg often appears in cranberry research
A 2024 review of ten randomised trials found a statistically significant result in studies reporting at least 36 mg of PACs daily. The pooled relative risk was about 0.82, or an estimated 18% lower relative risk.
However, 36 mg is not a universally proven effective dose. Cochrane found very uncertain evidence when comparing PAC amounts and no clear proof that higher doses always work better. Cranberry preparations and PAC testing methods also differ.
What PAC standardisation tells us
Standardisation means an extract is made to meet a PAC-related specification, helping with consistency. It does not tell you the PAC dose unless a milligram amount is given.
Our XTR Cranberry 100,000 is PAC-standardised, but its current information does not confirm a PAC amount in milligrams. We do not assume it contains 36 mg or matches any trial dose. The fresh-fruit equivalent is a different measurement.
Why we chose a focused cranberry extract for XTR
We chose a dedicated cranberry formula because we believe everyday support should be straightforward. Our XTR Cranberry 100,000 capsules contain 166.7 mg of concentrated North American cranberry (Vaccinium macrocarpon) extract per capsule, with a stated 600:1 extraction relationship.
That corresponds to an equivalent of 100,000 mg of fresh cranberry fruit. It describes the starting fruit associated with the extract, not the physical contents of the capsule, its PAC amount or a clinically proven prevention dose.
What we like is the focused format: cranberry rather than a broad blend, PAC standardisation for consistency, and a small vegetarian capsule. It is convenient if you prefer not to drink large amounts of sweetened cranberry beverages. That does not make capsules automatically more effective than juice.
We leave out artificial colours, flavours and preservatives, and use no ingredients derived from wheat, milk, soy, eggs, peanuts, tree nuts, fish or shellfish. We offer 60-capsule and 120-capsule options, plus a twin-pack format for people already satisfied that XTR suits them.
Our current maintenance direction is one capsule daily with food or as professionally prescribed. Follow the approved pack label. For suitable adults, XTR is a concentrated, easy-to-take option for everyday urinary tract wellbeing, without claims that our finished product achieved the results of clinical trials.
Where cranberry fits when infections keep coming back
For recurrent infections, cranberry can be one non-antibiotic option to discuss with a healthcare professional. A GP may recommend a urine culture, explore why infections return and review preventive care.
Drinking enough water, considering relevant personal and sexual health habits, and reviewing menopause-related changes may also help shape that conversation. Other clinician-recommended preventive treatments may be appropriate.
Our urinary tract support range offers everyday product options, but supplements do not replace testing, prescribed antibiotics or medical advice.
When to seek advice rather than rely on cranberry
New burning when passing urine, urgency, frequent urination, significant discomfort, blood in your urine or worsening symptoms call for healthcare advice, not more cranberry. Pregnant people and men with new urinary symptoms should seek assessment rather than self-treat.
Fever, shaking, side or back pain, vomiting or feeling seriously unwell may indicate a more significant infection and need urgent assessment. For a medical emergency in New Zealand, call 111.
If you take warfarin, avoid cranberry products because of a possible interaction, as advised by Medsafe NZ. For other blood thinners, check with your prescriber or pharmacist. Do not use XTR if you have kidney disease. If you have had oxalate kidney stones, ask your doctor first. During pregnancy or breastfeeding, use XTR only under professional supervision.
This article is general information, not personal medical advice. Your GP or pharmacist can help you decide what is suitable.
Common questions about cranberry and recurrent UTIs
Can cranberry actually help prevent recurrent UTIs?
Yes, for some women. The 2023 Cochrane review found that cranberry products probably reduce symptomatic, culture-confirmed UTIs in women with recurrent infections. This does not mean cranberry will protect everyone.
How much can cranberry reduce the risk of another UTI?
Across eight studies involving women with recurrent UTIs, the Cochrane estimate was a 26% lower relative risk. This is an average study result, not a 26-percentage-point drop, a personal guarantee or a clinical claim about Gold Health XTR Cranberry 100,000.
Does cranberry help if UTI symptoms have already started?
No. Cranberry is not a treatment for an active UTI. If burning, urgency, pain or other urinary symptoms begin or get worse, seek healthcare advice rather than increasing a supplement dose.
What are cranberry PACs, and is 36 mg the right amount?
PACs are cranberry plant compounds that may make it harder for some bacteria to attach to urinary tract cells. A 2024 review found benefit in studies using at least 36 mg of PACs daily, but no universal effective dose is established. A confirmed PAC amount in milligrams is not available for XTR Cranberry 100,000.
Is cranberry juice or a cranberry capsule better for daily use?
Both juice and capsules have been studied, and no one form is proven best for everyone. A capsule can be easier to take each day and avoids the added sugar found in many cranberry drinks.
What makes Gold Health XTR Cranberry 100,000 worth considering?
We use a concentrated 600:1 North American cranberry extract, standardised for PACs, in small vegetarian capsules. It is a practical option for suitable adults who want everyday urinary tract support, but our finished product has not been clinically proven to prevent UTIs.
A considered way to support urinary wellbeing
Cranberry has earned serious interest because human trials found fewer confirmed infections in some women with recurrent UTIs. The evidence is encouraging, although the benefit depends on the person and the preparation.
We offer XTR Cranberry 100,000 as a focused North American cranberry extract, PAC-standardised and easy to take in a small vegetarian capsule. For suitable adults, it is a practical choice for everyday urinary tract support alongside appropriate healthcare advice.
Explore our Cranberry collection for product details and formats, and see whether our cranberry support feels right for you.
References
- Cochrane (2023). Cranberries for preventing urinary tract infections.
- Stonehouse W et al. (2025). Whole cranberry fruit powder and recurrent UTI trial.
- Xiong Z et al. (2024). Cranberry PACs systematic review and meta-analysis.
- bpacnz (updated July 2026). Urinary tract infections: lower UTI management in adults.
- Healthify NZ. Recurrent urinary tract infections.
- Healthify NZ. Urinary tract infection in women.
- Medsafe NZ (2022). Warfarin: eat, drink and be wary.
